Validation of secondary data. Strengths and limitations

被引:48
作者
Hoffmann, F. [1 ]
Andersohn, F. [1 ,2 ]
Giersiepen, K. [1 ]
Scharnetzky, E. [1 ]
Garbe, E. [1 ,2 ]
机构
[1] Univ Bremen, D-2800 Bremen 33, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
关键词
Secondary data; validation studies; health services research; pharmacoepidemiology; Germany;
D O I
10.1007/s00103-008-0646-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Medical records databases (such as the General Practice Research Database-GPRD) and administrative databases (such as German Statutory Health Insurance (SHI) claims data) are useful sources for pharmacoepidemiology and health services research. However, these data are not primarily collected for research purposes. Validation studies are needed to examine their completeness and accuracy depending on the corresponding research question. This article reviews strategies for checks of internal consistency within the data from one SHI as well as between data from several SHIs and possibilities of internal data validation. Descriptive analyses of consistency can help to determine the integrity of data. The aim of internal validation is to separate uncertain from true cases based on information from secondary data alone or to reproduce known associations within the database. In addition external validation of secondary data is desirable using original prescriptions, medical records, hospital discharge letters and/or patient or physician interviews as a gold standard. A considerable number of external validation studies of diagnostic coding have been conducted within the GPRD. In contrast, such validation studies of German SHI claims data are mostly lacking and are urgently needed in the near future.
引用
收藏
页码:1118 / 1126
页数:9
相关论文
共 41 条
  • [11] GROBE TG, 2006, GEK REPORT AMBULANT
  • [12] Hormone replacement therapy and risk of venous thromboembolism: Population based case-control study
    Gutthann, SP
    Rodriguez, LAG
    Castellsague, J
    Oliart, AD
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7083): : 796 - 800
  • [13] Triptans in migraine - The risks of stroke, cardiovascular disease, and death in practice
    Hall, GC
    Brown, MM
    Mo, JP
    MacRae, KD
    [J]. NEUROLOGY, 2004, 62 (04) : 563 - 568
  • [14] Validity of gout diagnoses in administrative data
    Harrold, Leslie R.
    Saag, Kenneth G.
    Yood, Robert A.
    Mikuls, Ted R.
    Andrade, Susan E.
    Fouayzi, Hassan
    Davis, Judith
    Chan, K. Arnold
    Raebel, Marsha A.
    Von Worley, Ann
    Platt, Richard
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (01): : 103 - 108
  • [15] HASFORD J, 2004, MEMORANDUM NUTZEN NO
  • [16] Hauner H, 2007, DTSCH ARZTEBL, V104, pA2799
  • [17] Descriptive analyses of the integrity of a US Medicaid claims database
    Hennessy, S
    Bilker, WB
    Weber, A
    Strom, BL
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (02) : 103 - 111
  • [18] Validity of research significant information in German medication claims data over the years 2000-2006
    Hoffmann, F.
    Pfannkuche, M. S.
    Glaeske, G.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (18) : 945 - 949
  • [19] A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2
    Hoffmann, K.
    Mattheisen, M.
    Dahm, S.
    Nuernberg, P.
    Roe, C.
    Johnson, J.
    Cox, N. J.
    Wichmann, H. E.
    Wienker, T. F.
    Schulze, J.
    Schwarz, P. E.
    Lindner, T. H.
    [J]. DIABETOLOGIA, 2007, 50 (07) : 1418 - 1422
  • [20] Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population
    Huerta, C
    Castellsague, J
    Varas-Lorenzo, C
    Rodríguez, LAG
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (03) : 531 - 539